[Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial]

J Gynecol Obstet Biol Reprod (Paris). 2001 Sep;30(5):439-43.
[Article in French]

Abstract

Objective: To compare the effectiveness of misoprostol administrated intravaginally alone versus misoprostol with oxytocin infusion for termination of pregnancy at 13 to 29 weeks. Subjects and methods. Ninety women at 13-29 weeks requesting pregnancy termination were randomized to receive 200 microgram of misoprotol intravaginally every 12 hours either with oxytocin infusion or alone for up to 48 hours.

Results: The mean induction to abortion interval was significantly shorter in the misoprostol-oxytocin group than in the misoprostol alone group (22+/-10.8 hours versus 27+/-14.1 hours respectively p<0.05). The 48 hours successful abortion rates were 95% and 90% respectively. Abortion was complete in 79.1% and 62.5% respectively. Side effects were similar between groups.

Conclusion: Vaginal misoprostol associated with oxytocin infusion is more effective than misoprostol alone in termination of second-trimester pregnancy.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage*
  • Abortion, Therapeutic / methods*
  • Administration, Intravaginal
  • Adult
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infusions, Intravenous
  • Misoprostol / administration & dosage*
  • Oxytocin / administration & dosage*
  • Parity
  • Patient Selection
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Time Factors

Substances

  • Abortifacient Agents, Nonsteroidal
  • Misoprostol
  • Oxytocin